Low-Cost Microfluidic Mixers: Are They up to the Task?
Authors:
- Jade ForresterJFJade Forrester
- Callum G. DavidsonCDCallum G. Davidson
- May BlairMBMay Blair
- Lynn DonlonLDLynn Donlon
- Daragh M. McLoughlinDMDaragh M. McLoughlin
- Chukwuebuka R. ObioraCOChukwuebuka R. Obiora
- Heather StockdaleHSHeather Stockdale
- Ben ThomasBTBen Thomas
- Martina NutmanMNMartina Nutman
- Sarah BrockbankSBSarah Brockbank
- Zahra RattrayZahra Rattray
- Yvonne PerrieYvonne Perrie
Open Access
- 25 April 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 566
Abstract
Background/Objectives: Microfluidic mixing has become the gold standard procedure for manufacturing nucleic acid lipid-based delivery systems, offering precise control over critical process parameters. The choice and design of microfluidic mixers are often seen as a key driving force affecting the critical quality attributes of the resulting lipid nanoparticles (LNPs). Methods: This study aimed to evaluate LNPs manufactured using two low-cost microfluidic mixers alongside manual mixing (pipette mixing (PM)), followed by characterization studies using orthogonal analytics as well as expression studies to establish whether low-cost microfluidic manufacturing methods are suitable for bench-scale and high-throughput research. Results: The results show that all manufacturing methods can produce LNPs with sizes ranging between 95 and 215 nm with high encapsulation (70–100%), and enhanced analytics showed variations between the LNPs produced using the different mixers. Despite these differences, pipette mixing production of LNPs demonstrated its application as a high-throughput screening tool for LNPs, effectively distinguishing between different formulations and predicting consistent expression patterns both in vitro and in vivo. Conclusions: Overall, these results validate the use of low-cost microfluidic mixers without compromising the efficiency and integrity of the resulting LNPs. This study supports the increased accessibility of small-scale LNP manufacturing and high-throughput screening.Keywords
Funding Information
- Innovate UK (10058505, EP/V028960/1, EP/W037009/1, EP/X528493/1, MC_PC_17135, MC_UU_00034/7, H17007)
- James Weir Foundation (10058505, EP/V028960/1, EP/W037009/1, EP/X528493/1, MC_PC_17135, MC_UU_00034/7, H17007)
- University of Strathclyde Nanomedicines Centre (10058505, EP/V028960/1, EP/W037009/1, EP/X528493/1, MC_PC_17135, MC_UU_00034/7, H17007)
- UK Engineering and Physical Sciences Research Council (10058505, EP/V028960/1, EP/W037009/1, EP/X528493/1, MC_PC_17135, MC_UU_00034/7, H17007)
- Engineering and Physical Sciences Research Council (10058505, EP/V028960/1, EP/W037009/1, EP/X528493/1, MC_PC_17135, MC_UU_00034/7, H17007)
- MRC (10058505, EP/V028960/1, EP/W037009/1, EP/X528493/1, MC_PC_17135, MC_UU_00034/7, H17007)
- SFC (10058505, EP/V028960/1, EP/W037009/1, EP/X528493/1, MC_PC_17135, MC_UU_00034/7, H17007)
This publication has 29 references indexed in Scilit:
- Frit-inlet asymmetric flow field-flow fractionation for the analysis of lipid nanoparticle-protein interactionsJournal of Chromatography A, 2025
- Enhancement of mixing and reaction efficiency of various fluids applications at different microfluidic configuration and designChemical Engineering and Processing - Process Intensification, 2024
- The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropismEuropean Journal of Pharmaceutics and Biopharmaceutics, 2023
- The journey of a lifetime — development of Pfizer’s COVID-19 vaccineCurrent Opinion in Biotechnology, 2022
- Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle SizePharmaceutical Research, 2022
- Rapid scale-up and production of active-loaded PEGylated liposomesInternational Journal of Pharmaceutics, 2020
- Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: A case study using protein-loaded liposomesInternational Journal of Pharmaceutics, 2020
- Liposomes: Advancements and innovation in the manufacturing processAdvanced Drug Delivery Reviews, 2020
- A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2019
- State‐of‐the‐Art Design and Rapid‐Mixing Production Techniques of Lipid Nanoparticles for Nucleic Acid DeliverySmall Methods, 2018